EP1546723A2 - Lecture de reseaux fluorescents - Google Patents

Lecture de reseaux fluorescents

Info

Publication number
EP1546723A2
EP1546723A2 EP03788571A EP03788571A EP1546723A2 EP 1546723 A2 EP1546723 A2 EP 1546723A2 EP 03788571 A EP03788571 A EP 03788571A EP 03788571 A EP03788571 A EP 03788571A EP 1546723 A2 EP1546723 A2 EP 1546723A2
Authority
EP
European Patent Office
Prior art keywords
array
reader
substrate
anay
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03788571A
Other languages
German (de)
English (en)
Other versions
EP1546723A4 (fr
Inventor
Jean I. Montagu
Robert H. Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decision Biomarkers Inc
Original Assignee
CLINICAL MICROARRAYS Inc
Decision Biomarkers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31892097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1546723(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CLINICAL MICROARRAYS Inc, Decision Biomarkers Inc filed Critical CLINICAL MICROARRAYS Inc
Publication of EP1546723A2 publication Critical patent/EP1546723A2/fr
Publication of EP1546723A4 publication Critical patent/EP1546723A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00306—Reactor vessels in a multiple arrangement
    • B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315—Microtiter plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00351—Means for dispensing and evacuation of reagents
    • B01J2219/00387—Applications using probes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00527—Sheets
    • B01J2219/00533—Sheets essentially rectangular
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632—Introduction of reactive groups to the surface
    • B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • B01J2219/00641—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being continuous, e.g. porous oxide substrates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00725—Peptides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/0074—Biological products
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • G01N21/274—Calibration, base line adjustment, drift correction

Definitions

  • the field to which this disclosure relates is clinical micro-array technology, for instance clinical research and clinical diagnosis.
  • Micro-array technology has developed over the past decade and more. It is employed in the investigation of biological molecules, in particular, nucleic acid and amino acid materials. Effective use has been made of the technology in understanding the genome and in drug discovery. It has been predicted that the technology would ultimately develop to enable practical use in the clinic, e.g. for clinical investigations and clinical diagnosis, but that prospect has seemed far off. Among reasons for this being only a long-term hope has been the very high cost of the required equipment, the time involved in carrying out assays, and the high level of experience and skill required. As is well known, micro-arrays are used by creating a field of features or spots of different analytes that are tagged or marked if certain components are present.
  • fluorescent tags While marking has often been by radioisotope tags, fluorescent tags have come into wide usage for a number of reasons including the ease by which the materials can be handled and out of safety considerations. Typically it is desired to represent an assay by a complete image of an array, or small set of related arrays.
  • the reader of fluorescent micro-arrays is key to the use of the arrays.
  • the reader records presence and degree of fluorescence at each of the precisely located features in the array in response to exposure to photoexcitation. After consideration of numerous arrangements for reader design, a few successful technologies have found acceptance. These universally have required precise and costly mechanical movements, as well as extensive optics or software. In one case, a rapidly oscillating scanner arm moves a tiny lens for reading one pixel at a time in one coordinate, in a confocal configuration, while the image of the array in the other coordinate is developed by precise, gradual advance using a microscope stage.
  • the stage is a device that creates precise movements of micron or sub micron accuracy and is costly to manufacture and along with the other components.
  • software is used to assemble the image from the vast array of gathered pixels.
  • Another technique has been to image highly magnified views of portions of the overall array, by use of precision stage movement between the taking of each of the series of magnified images of the small portions of the array, and then electronically merging or "stitching" the small field image frames together to electronically produce an image of the complete array.
  • Prior proposals or speculation for employing a solid state array of sensors to image an entire array at one taking have not resulted in practical solution of the entire set of problems, i.e., simultaneously achieving high accuracy and high speed of operation at reasonable cost.
  • Embodiments can satisfy the crucial low cost need for a clinical reader, along with need for reasonably high speed and ease of operation, and while achieving the high level of accuracy required for medical use.
  • the basic reader geometry should be based on dark field illumination, e.g. light reaching the two-dimensional array at an acute angle of 20 to 50 degrees, which should be mated with two-dimensional imaging on a solid-state detector array, such as that of a CCD sensor or CMOS array, with mapping on that array being of a scale of the same order of magnitude as the array of biological features.
  • NA numerical aperture
  • Embodiments within these constraints are capable of imaging an entire array in a single frame, without movement or stitching of components of the array. It is realized that cooperation of the features in the instrument, preferably with further novel enhancements to be described, can make up for the inherent limitations of such an arrangement, i.e. its relatively large depth of field, and, when using preferred relatively inexpensive lighting, such as by high intensity diodes, its non-uniform illumination.
  • the resulting apparatus because of its simplicity and lack of precise moving parts or expensive optics, can be made available to clinics at a cost that makes the system and technique practical. In such manner, practical, high-speed clinical imaging is made possible even now, and from this, great benefits to medicine and patient care can be obtained.
  • an array reader is provided that is suitable for clinical purposes for reading a two-dimensional array of features on a planar substrate, in which the features carry photo-responsive markers, the markers capable of emitting light upon excitation, the array reader comprising an illumination system for simultaneously exciting multiple photo-responsive markers distributed in a two-dimensional array over the substrate, and an image collection and recording system having a field of view for emissions from the markers on the substrate, wherein the illumination system comprises a light source arranged to flood the two-dimensional array with light at an excitation wavelength, along an illumination path disposed at an angle ⁇ between about 20 and 50° to the plane of the substrate, the image collection and recording system having an image-acquiring axis substantially normal to the plane of the substrate carrying the array, employing a two-dimensional sensor comprising a solid-state array of photosensitive elements, e.g.
  • CMOS complementary metal-oxide-semiconductor
  • the image collection and recording system constructed and arranged to apply an image of the array of markers upon the solid-state array of size of the same order of magnitude as the size of the array, e.g. within a range of magnification of up to about 25% or reduction down to about 75%, the image collection, and recording system having an intermediate numerical aperture NA, to enable recording the image of fluorescence from the excited two-dimensional array with clinical accuracy and without translation of the array.
  • the array reader image collection and recording system has its nearest component spaced at least 5 mm, preferably at least 10 millimeter, from the substrate or its support, the component constructed and arranged to provide space below the component for the illumination path to the two-dimensional array on the substrate.
  • the image collection and recording system has a field of view on the substrate of areas between about 50 mm 2 and 300 mm 2 .
  • the illumination system comprises one or more light-emitting diodes.
  • the illumination system and especially the diode-based system, is constructed and arranged to provide excitation illumination over the two-dimensional array on the substrate of a power density greater than 30 mW/cm 2 and preferably the image collection and recording system includes a timer cooperatively related to the illumination system to provide exposure sufficient to produce a fluence of excitation radiation at the substrate greater than about 15 mJ/cm 2 across the two-dimensional array.
  • the array reader has a field of view of diameter of the order of 10 mm or more.
  • Each feature of the array of interest is imaged onto a minimum of 50 pixel elements of the solid state array, for example upon CCD or CMOS elements.
  • the pixels (i.e. sensor elements) of the solid state array are selected to be of 9 micron dimension, albeit, if larger field were to be imaged, using the same arrangement, pixels down to about 4.5 micron may be selected, and more reduction of image may be employed).
  • the array reader is constructed and arranged to deliver to the solid state sensor an image of the field of view that is not magnified, preferably the reader being constructed and arranged to deliver to the solid state sensor array an image of the field of view reduced between about 30% and 50%.
  • the array reader is constructed to image spots each of diameter at least about 80 micron, preferably at least 100 micron diameter.
  • the array reader is constructed and arranged to produce, during a single imaging interval, an image of an array of at least 100 spots each of 300 micron diameter, or of at least 400 spots each of 150 micron diameter.
  • the array reader is combined with a carrier for the array comprising a substrate layer carried by a support body, the image collection and recording system residing on the same side of the substrate as does the array of features such that the path of illumination reaches the array before reaching the support body, the carrier constructed to absorb excitation radiation penetrating beyond the layer, preferably the support body being transparent, e.g. glass, and between the substrate layer and the transparent body resides a substantially opaque adherent layer capable of substantially blocking excitation radiation tending to enter the transparent body, preferably the substantially opaque layer comprising a layer of metal oxide.
  • the array reader is combined with a carrier for the array in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body.
  • the array reader is combined with a carrier for the array that comprises an ultra- thin substrate layer on a support body, i.e. the substrate having a thickness less than 5 micron, preferably less than about 3 micron.
  • the array reader is combined with a carrier in which the array is disposed on a substrate comprising a clear layer of nitrocellulose or polystyrene.
  • the array reader is combined with a carrier in which the substrate is a nitrocellulose membrane that is porous at least in its outer region.
  • the array reader is combined with a substrate carrying excitation energy reference features distributed across the two-dimensional array of features, the image collection and recording system including a normalizing arrangement for normalizing data detected in the vicinity of respective reference features based on the quantity of detected emission from the respective reference features.
  • the array reader has an illumination system which comprises at least two different light source sub-systems respectively of substantially different wavelengths, each associated with a respective optical system delivering light along a path, the paths of the sub-systems to the substrate lying along respectively different axes, the axes being spaced apart about the substrate, in certain preferred embodiments there being two different light source subsystems the paths of which are disposed on diametrically opposite positions about the substrate.
  • the array reader has an illuminating system which includes light sources selected respectively to excite Cy3 and Cy5, and the image collection and recording system includes changeable band-pass filters suitable to permit passage of emissions respectively from Cy3 and Cy5 or a single band-pass filter is provided suitable to permit passage of multiple band-pass emissions such as both the band-pass emission of Cy3 and of Cy5.
  • the image collection and recording system of the array reader is adjustable between at least two settings, the first and second settings constructed and arranged respectively to form a single image of an array format of dimensions 6.5 mm x 9.0 mm and of an array format comprising two separated sub-windows, each of dimensions 4.5 mm x 4.5 mm disposed within a 4.5x 13.5 mm rectangle.
  • the array reader illumination system includes a diode light source and a homogenizer effective to reduce variation in flux density across the field of illumination, in certain preferred embodiments the homogenizer comprising an elongated transparent, internally reflective rod, which may be straight or curved and may have round, square or rectangular cross section, and be twisted or untwisted.
  • the array reader has an image collection and recording system constructed and arranged to resolve the image on the solid state sensor array at resolution no finer than about 10 micron, in certain preferred embodiments the resolution being between about 12 and 15 micron.
  • the array reader has an image collection and recording system which includes an interference filter, collection optics of the system preceding the filter constructed to direct collected rays in parallel to the filter, and imaging optics constructed to image parallel rays leaving the filter upon the solid state sensor.
  • the array reader is constructed to be used with an array support that holds more than one array, and wherem the reader is constructed and arranged to read and process each array as an independent array.
  • the invention also includes a method of conducting an assay comprising preparing a two-dimensional spotted array of amino or nucleic acid features on a substrate, preferably by spotting liquid samples thereon, in which features in the array carry fluorescent markers and employing the reader of any of the foregoing descriptions to read the array.
  • Preferred embodiments of this aspect of the invention have one or more of the following technical features.
  • the assay is a diagnostic immuno assay based on protein derived from blood, in certain embodiments preferably the immunoassay is of an antibody capture configuration, for instance adapted, by immobilized antibodies to detect or monitor for malignant cancer, e.g. to detect ovarian cancer for initial diagnosis or to monitor patients at risk for relapse.
  • the substrate is disposed within a sealed disposable bio-cassette and imaging is performed through a transparent window visually accessing the substrate, or a transparent body forming a side of the bio-cassette carries the substrate, the substrate being transparent and the array being accessed visually by the array reader through the transparent body and through the substrate.
  • the array for reading an array on a substrate, in certain preferred embodiments the array includes intensity calibration markers of fluorescing character generally proportional in emission intensity to excitation level over the range of operable illumination intensities, and the system or method includes forming an image of the array employing the array reader, and normalizing recorded array data based on quantitative data acquired from nearby intensity calibration markers.
  • Another aspect of the invention is a fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two- dimensional array by light at fluorophore-excitation wavelength, by employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, and (5) analyzing (e.g. by computer) the fluorescence image for the presence of the disease.
  • Preferred embodiments of this aspect of the invention have
  • the method is performed in which the step of simultaneously illuminating the entire two-dimensional array is carried out by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30m /cm 2 .
  • the method is carried out in a way in which fluorescence intensity reference features are distributed through the array and the detected radiation from the biomarkers is normalized by the reader based on the response of the references to the illumination.
  • the method is carried out in a way in which at least 50 pixels of the solid-state sensor represent the image of a feature of the array.
  • the method is performed in which the biomarkers attach to antibodies.
  • the method is performed in a way in which the array is formed to immobilize protein biomarkers selected to diagnose presence of ovarian cancer.
  • Another aspect of the invention is a method of reading an array on a substrate having features that include fluorophores, in which the array includes intensity calibration features of fluorescing character generally proportional in emission intensity to their illumination over the range of operable illumination intensities, including, forming an image of the array employing an array reader, and normalizing recoded array data based on quantitative data acquired during the reading of the array from nearby intensity calibration features within the array.
  • the method is adapted to perform diagnosis for a disease for which there is a set of known protein biomarkers in blood or other body constituent, comprising the steps of (1) providing a two-dimensional array of different reagents on a substrate, the reagents respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease, and including with the array the intensity calibration features (2) exposing the array to fluorophore-labeled blood or body-constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent, (3) while the array is stationary, exciting the array by simultaneously illuminating the entire two-dimensional array by light at fluorophore-excitation wavelength employing dark field illumination, (4) capturing a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array, (5) normalizing the recorded array data based on the calibration features in the array and (6) analyzing
  • the method is performed by illuminating the entire two-dimensional array for forming the image by directing excitation radiation from a diode or set of diodes to produce illumination at a wavelength selected to excite the fluorophore, at a power density of at least 30mW/cm 2 .
  • the method is performed under conditions in which at least 50 pixels of a solid- state sensor represent the image of a feature of the array.
  • the method is employed to perform a diagnosis in which features of the array include antibodies, in one important case the features of the array are selected to diagnose the presence of ovarian cancer.
  • FIG. 1 is a diagrammatic view of an array reading system.
  • FIGs. 2 A and 2B are diagrammatic views of illuminating devices for the reader.
  • FIG. 3 is a plot of relative intensity of illumination versus angle relative to a central axis for a high intensity LED.
  • FIG. 4 A depicts a spotting pin and reservoir suitable to form spots of biological material or intensity calibration spots
  • FIG. 4B depicts an array in which the calibration spots are strategically distributed through the array of spots of biological material
  • FIG. 4C being a magnified view
  • FIG. 4D a plan view.
  • FIG. 5 depicts the mapping of a spot upon the array of solid state detection elements of the sensor.
  • FIG. 6 is a diagrammatic representation, on highly magnified scale, of a carrier comprising a transparent rigid support body, bearing an opaque layer, ultra-thin substrate and spots of the array on the substrate. Illumination from the same side as the array is shown.
  • FIG. 7 A is a diagrammatic representation of a preferred clinical array reader, while FIG. 7B shows another clinical array reader.
  • FIG. 8 illustrates two array formats imageable by the array reader of FIG. 7 A.
  • FIG. 9 is a diagram representing the steps of an array-reading method.
  • FIG. 10 is a diagram representing the steps of a method for normalizing the intensity level of pixels in the recorded image.
  • FIG. 11 is a diagram representing the steps of a fluorescence reader-based diagnostic method.
  • an array reading system 100 includes an array reader 110, a substrate 102 bearing a two-dimensional array of features 103 (e.g. spots of bio- material such as amino or nucleic acid) some of which, depending on the assay, carry fluorescent material, and a computer 104 for processing images recorded with the array reader 110.
  • the array reader 110 includes an illumination system 120 and an image collection and recording system 140.
  • the substrate 102 is positioned, with a positioner 105, below the image collection and recording system 140, with a distance between them h that is large enough for light from the illumination system 120 to flood the two dimensions of the array 103, preferably h having the value of at least 5 mm and generally preferably at least 10 mm.
  • a preferred source of the illuminating light has an output between about
  • the features on the substrate contain material capable of emitting light within a narrow fluorescence spectrum upon excitation with light of selected wavelength from the illumination system 120. Any available fluorescent dye maybe employed, presently Cy3 and Cy5 being common selections.
  • the image collection and recording system 140 collects the fluorescent light and records a resulting image of the features or spots, the optical system selected to produce a flat field of view.
  • the image-acquiring axis 141 is substantially normal to the plane of the substrate 102.
  • the illumination system 120 uses dark field illumination such that light from the illumination system 120 is directed along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102 to prevent illumination light reflected from the substrate 102 from entering the image collection and recording system 140.
  • the imaging optics 142 project an image 144 of the array 103 on a two-dimensional array of solid state detecting elements comprising sensor 146.
  • This solid state array is of dimensions of the same order of magnitude as are the dimensions of the array of bio- material spots.
  • the imaging optics system 142 is designed to have such a large field- of-view that the entire array 103 is mapped onto the sensor 146.
  • the two arrays are relatively sized such that a spot of bio-material is resolved on at least 50 pixels, preferably with spot size of the order of 100 micron, of the order of 100 pixels, or with spot size of 300 micron, of the order of 300 pixels.
  • the physical size Dj of the image 144 is approximately the same as the physical size D 0 of the array 103, biased toward reduction, i.e. preferably not magnified more than about 25% or reduced more than about 75%.
  • the array is not magnified, and preferably is reduced in the range between 30% and 50%. This provides the very important feature of there being no requirement to translate the array 103 by a precision stage relative to the reader 110 to acquire the image or stitch together multiple images of small sections to form a single image of the array 103.
  • the illumination system 120 includes a high intensity LED 122 for emitting light within an excitation band (e.g., green) designed to excite a fluorescence spectrum of a material in a spot (e.g., Cy3).
  • An excitation filter 124 is used to further limit the excitation wavelength band.
  • the spatial distribution of the light is shaped with an optical system such as a pair of lenses 126 and 128 for near uniform illumination of the two-dimensional array 103 on the substrate 102.
  • more than one LED can be distributed about the array 103, also arranged to emit light along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102.
  • the illumination system 120 includes a high intensity LED 122 for emitting light within an excitation band (e.g., green) designed to excite a fluorescence spectrum of a material in a spot (e.g., Cy3).
  • An excitation filter 124 is used to further limit the excitation wavelength band.
  • the spatial distribution of the light is
  • a homogenizer 130 with suitable lenses integral with its ends (not shown) reduces variation in flux density across the field of illumination onto the two-dimensional array 103 situated on the substrate 102. It comprises a solid transparent rod suitably designed or clad to have 100% internal reflection and of length relative to diameter selected to produce the desired homogenization effect, to render the distribution of illumination more uniform function.
  • the homogenizer 130 accepts light up to an acceptance angle of approximately 45°.
  • the end of the homogenizer 130 is arranged to emit light along a path that has an angle ⁇ between about 20° and 50° to the plane of the substrate 102.
  • the detected intensity for spots of an array can be normalized against the detected value of radiation received from near-lying calibration spots during image processing, thus enabling tolerance of non-uniformity in radiation, as may occur in a 0 low cost lighting system.
  • the technique may also be effective to compensate for imprecise location of the array under the reader.
  • FIG. 3 shows a non-uniform illumination pattern generated by a typical high-intensity LED, plotted as relative intensity as a function of angle from the center axis.
  • the intensity of fluorescent light recorded by the solid state sensor array at a location in the image corresponding to a calibration spot is used to infer the local illumination intensity, which is used to normalize the signal level recorded at neighboring spots on the sensor array.
  • Different calibrating spots typically local, respectively, to different sets of spots of unknown intensity are used.
  • FIG. 4A depicts a well of a microwell plate containing a fluorescent calibration composition in which a pin 161 is dipped to receive the composition for spotting a substrate 102 e.g. polyimide polymer (KaptonTM) dissolved in a volatile solvent.
  • FIG. 4B shows diagrammatically a spotted array 103 of biological spots 1 6 among which is a pattern of fluorescent calibration spots 164 produced with the composition of FIG. 4A.
  • FIG. 4C is a magnified view of a portion of a substrate 102 containing, in addition to biological spots 166, fluorescent intensity calibration spots 164.
  • FIG. 4A depicts a well of a microwell plate containing a fluorescent calibration composition in which a pin 161 is dipped to receive the composition for spotting a substrate 102 e.g. polyimide polymer (KaptonTM) dissolved in a volatile solvent.
  • FIG. 4B shows diagrammatically a spotted array 103 of biological spots 1 6 among which is a pattern
  • 4D is a diagrammatic plan view, on an enlarged scale, of an array 103 of biological spots 166, showing a relative arrangement of calibration spots 164. This arrangement enables normalization of intensity variations across the entire array 103.
  • the same intensity calibration spots can also be used as spatial fiducials for locating the array or the overall outline of the array may be employed for locating it to the control system.
  • FIG. 5 shows a section of a CCD near a border of the image of a spot 202 corresponding enabling resolution of a feature in the array by approximately 291 pixels.
  • FIG. 6 illustrates important aspects of a preferred substrate 102.
  • An ultra-thin layer 302 of material e.g., thinner than about 5 microns, preferably less than 3 microns
  • nitrocellulose or polystyrene As a film it is transparent, though in other cases an ultra-thin porous nitrocellulose membrane may be employed.
  • the substrate supports the array 103 of features. The being ultra-thin, it limits the amount of fluorescence emitted by the substrate layer 302 itself.
  • An opaque layer 304 such as sputtered metal-oxide helps to prevent illumination light 300 from penetrating into, and exciting fluorescence within, the rigid support 306 below (e.g. the substance of a glass microscope slide). This helps to counter potential auto-fluorescence capture from the support layer 306 caused by the large depth of focus due to not using a high numerical aperture optical system.
  • the array reader 110 enables imaging of an array of fluorescently labeled proteins, as well as other potential widespread uses, such as imaging proteins labeled with luminescent tags, and with other bio-materials labeled with fluorescent or luminescent tags.
  • the array reader 110 may be used to advantage with viruses, peptides, antibodies, receptors, and other proteins; with a wide range of other labeled biological materials including plant, animal, human, fungal and bacteria cells; and with labeled chemicals as well.
  • the array reader 110 is designed for rapid imaging of immunoassay arrays of the size relevant to clinicians, with typically fewer than 1000 spots.
  • the array reader 110 also enables performing immunoassays of multiple biomarkers (e.g., for ovarian cancer) simultaneously. Diseases with a set of known protein biomarkers in blood or other body constituents, can therefore be diagnosed more easily. After providing a two-dimensional spotted array of reagents on a substrate, the reagent spots are exposed to fluorophore-labeled blood or other body- constituent extracted from an individual suspected of having the disease. The resulting array of spots are then read by the array reader 110.
  • multiple biomarkers e.g., for ovarian cancer
  • Array reader 400 includes a LumiLed high intensity LED 402 (Luxeon green 535 nm, 5 watt LED, part # LXHL-LM5C available from Lumileds Lighting U.S., LLC, San Jose, CA) with a green peak wavelength for excitation of Cy3, and a second LumiLed high intensity LED 404 (Luxeon red-orange 617 nm, 1 watt LED, part # LXH-MH1B) with a peak wavelength for excitation of Cy5.
  • LumiLed high intensity LED 402 (Luxeon green 535 nm, 5 watt LED, part # LXHL-LM5C available from Lumileds Lighting U.S., LLC, San Jose, CA) with a green peak wavelength for excitation of Cy3
  • a second LumiLed high intensity LED 404 (Luxeon red-orange 617 nm, 1 watt LED, part # LXH-MH1B) with a peak wavelength for excitation of Cy5.
  • Both LEDs have a low temperature coefficient, of about 0.04 nm/deg C, and a narrow band peak wavelength tolerance, typically 8nm for Cy5 and 30 nm for Cy3. These LEDs are available with a 10% to 20% conversion efficiency and a typical specification of 110 mW of continuous-wave output power that can be peaked by 50% for a second at low duty cycle to yield about 150 mW, nearly all within the pass bands of a Cy3 excitation filter 406 (Chroma filter part # HQ 535/50, available from Chroma Technologies, Rockingham, NT) and the Cy5 excitation filter 408 (Chroma filter part # HQ 620/60). The f/1 cone (marked by lines 150 at 30° in the illumination pattern shown in FIG.
  • LEDS have a long life, and allow straightforward implementation of multicolor fluorescence.
  • the green LED 402 uses a pair of Kohler lenses 412, and the red- orange LED 404 uses a pair of Kohler lenses 414, so that both LEDs deliver a nearly uniform beam over the 6.5 x 9.5 mm 2 field-of-view of the array 103.
  • the LEDs are mounted on heat sinks available from their supplier.
  • Positioning of the substrate 102 relative to the viewing axis of the reader is performed by a positioner 105, e.g. a Geneva drive, with spatial resolution e.g. of 0.1 or 0.2 millimeter having a positional accuracy for instance of about 0.1 - 0.2 mm.
  • the positioner 105 can be used to automatically shift from imaging one array to another, either on the same or a different substrate, but of course is not of the precision or cost of a microscope stage and plays no part in generating the components of an image of the array.
  • the same substrate can carry many arrays without the need to precisely position the arrays relative to one another, and the positioner 105 acts to move one after another into position for imaging.
  • the substrate has alignment marks, "fiducials", that aid in the positioning, for instance sets of distinctive marks that designate the comers of rectangular arrays.
  • the array 103 is imaged onto the CCD sensor 420 by a pair of commercial CCD lens assemblies 422, 422' (Westech CCD lens assemblies #2105 and #2131, available from Westech Optical Corporation, Penfield, NY), lens 422 being used in an unusual way relative to the purpose of its original design.
  • a band-pass filter 424 (Chroma Technology part # 68030 for Cy5, Chroma part # 57030 for Cy3) located in between the two lenses selectively transmits only light within the excited fluorescence spectra.
  • the image of one 6.5 x 9.5 mm field-of-view (see 502, Fig. 8) is projected onto the CCD sensor 420 reduced by a factor of 0.707, whereas the image of two separated sub- arrays, lying in a rectangle 4.50 x 13.5 mm is reduced by a factor of 0.5.
  • the lenses are assembled to operate with a 0.42 NA on the object side (facing the array 103).
  • the array 103 can be imaged onto the CCD sensor 420 with the lens assemblies 422 assembled to operate with an NA as large as 0.52.
  • the CCD sensor 420 is cooled with a Peltier cooler 426 (as in the CCD-based camera from Santa Barbara Instrument Group, Inc., Santa Barbara, CA, Model ST-7x ME) to reduce dark current noise.
  • the cooler 426 has the capability to cool the CCD sensor 420 to 50° C below ambient if necessary.
  • read-out noise generated upon conversion of the stored charge in a pixel into a voltage, is a dominant source of noise and to the extent its effects are not eliminated, read-out noise determines the minimum light intensity that can be detected. As this noise is random and the fluorescent light from the spots is not, most of its effects can be reduced by the "on board binning," dark field subtraction, time and frame integration, software analysis, and using a large number of pixels imaging each spot.
  • imaging in a dark field mode may also be accomplished with direct illumination at angle ⁇ as shown and CCD sensor 24 positioned to view the array along axis A normal to the plane of the array via collection optics 27, spaced a distance h from the substrate.
  • the substrate layer may be microporous partially or throughout its depth or may be a solid film or a modified solid film, preferably in any of these cases being an ultra-thin coating or membrane of less than 5 micron thickness.
  • light for direct illumination enters along an illumination axis A', at an acute angle ⁇ to the plane of the array.
  • Distance h must be selected to enable such direct illumination, with angle ⁇ ranging between about 20° and 50°, here shown at 45°.
  • Light L originates from a source 112a, 112b or 112c of wavelength selected to excite the fluorophore tag of the array, passes via dichroic mirrors 156b, 156c to mirror 116 located to the side that directs the illumination along axis A' at angle ⁇ , onto the fluorophore-tagged array of spots resident on the ultra-thin substrate 20 or 20'.
  • the array of spots may use a carrier that comprises an ultra-thin substrate layer on a support body, or a carrier in the form of a transparent layer carried by a transparent body, the image collection and recording system lying beyond the transparent body on the same side of the array as the transparent body.
  • the fluorescent emissions are collected by lens 27, through a selected filter 28A, B or C, thence through lens 26 to CCD camera 24 under computer control 32.
  • the background subtraction technique is used with this system.
  • the immunoassay arrays are limited to 400 microassay spots.
  • the array format is then an important design issue.
  • the size and number of pixels of the CCD's chip and the configurations of commercial spotting arrayers are important constraints to be balanced against each other in the design of the reader and array.
  • the size of the array must be matched to the CCD's parameters.
  • spotter pin or tip configurations limit the choice of reservoirs for loading the spotting or printing head with source material, and also limit possible array configurations.
  • Disposable microtiter plates with either 96 or 384 wells are the typical reservoirs used.
  • a first format 502 field-of-view covers one 6.5 x 9.5 mm 2 array
  • a second format 504 field-of-view covers two 4.5 x 4.5 mm arrays.
  • 300-micron diameter spots, 500 microns on center yielding a spot occupancy of 36%
  • each spot will be conjugated to about 291 pixels.
  • 150-micron diameter spots, 333 microns on center each spot will be conjugated to about 91 pixels.
  • the large number of pixels per spot permits the on board 3x 3 binning option available with the CCD sensor to increase signal-to-noise ratio.
  • the immediate background is subjected to the same averaging to yield a sensitive and reliable fluorescence signal level.
  • Arrays can be formed with each of the formats using either of the two spot sizes. These arrays can be printed with all commercial arrayers/printers, such as the Affymetrix Pin and Ring Arrayer, starting with either 96 or 384 microtiter plates as the source material loading reservoir.
  • the signal-to-noise ratio improves as the square root of the ratio of integration time or the number of frames. A 5 second read time versus 0.5 seconds improves the signal-to-noise ratio by approximately 3.16 times.
  • the signal-to-noise ratio can also be increased by increasing the number of
  • LEDs e.g. to as many as 4 for each of the 2 wavelengths, to raise the power level to 160mW/cm2.
  • these options increase the signal to noise ratio by as much as a factor of 13 by substantially raising the fluence to l,120mJ/cm 2 .
  • Photo- bleaching a possible consequence, depending upon the dyes etc., may limit this approach in particular circumstances.
  • the substrate can be a glass slide, or alternatively, a sealed disposable bio-cassette where imaging is performed through a transparent window within the substrate.
  • a method for multi-biomarker assay includes the step 600 of providing a two-dimensional spotted array of amino or nucleic acid features on a substrate, where features throughout the array carry photo-responsive sensitive markers.
  • the illumination source of the array reader illuminates the array along an illumination path at an angle ⁇ between about 20 and 50° to the plane of the substrate.
  • the image collection and recording system then collects excited fluorescent light along an image- acquiring axis that is substantially normal to the substrate, followed by the step 604 of recording an image of the array of bio-material spots on the solid array of a CCD sensor, followed by the step 606 of normalizing the intensity level of pixels in the recorded image using intensity calibration markers.
  • this calibration occurs as an integrated action in the imaging of each array. It is to be distinguished from pre-reading calibration of the overall instrument, a normal but not totally effective procedure.
  • a method for normalizing the intensity level of pixels in the recorded image includes the step 1004 of determining pixels that detect fluorescence from position calibration spots located at corners of an array 1002. The resulting position information is then used to locate pixels that correspond to multiple "data sets" across the two-dimensional image. Each data set contains pixels corresponding to biology spots, and pixels corresponding to an intensity calibration spot. For each data set, including a "data set n,” the method includes the step 1006 of detecting intensity recorded by pixels representing the intensity calibration spot n, the step 1008 of detecting intensity recorded by pixels representing each biology spot in data set n, and the step 1010 of normalizing the intensity data for each biology spot using the intensity of the intensity calibration spot. After intensity data is normalized for each data set, in a final step 1012, the entire image is represented according to the normalized data for all of the data sets.
  • a fluorescence reader-based diagnostic method for a disease for which there is a set of known protein biomarkers in blood or other body constituent, includes the step 1102 of providing a two-dimensional array of different reagents on a substrate.
  • the reagents are respectively specific to bind members of a set of the biomarkers capable of diagnosing the disease.
  • the method then includes the second step 1104 of exposing the array to fluorophore-labeled blood or body- constituent extract of an individual containing the biomarkers if present in the individual's blood or body constituent.
  • the reader While the array is stationary, in a third step 1106, the reader excites the array by simultaneously illuminating the entire two- dimensional array by light at a fluorophore excitation wavelength, employing dark field illumination. In a fourth step 1108, the reader then captures a fluorescence image of the entire two-dimensional excited array on a single frame of an imager comprising a solid state array. The method then includes the step 1110 of analyzing the fluorescence image for the presence of the disease.
  • the assay is a diagnostic immunoassay based on protein derived from blood, and can detect or monitor for malignant cancer, such as ovarian cancer, for initial diagnosis or to monitor patients at risk for relapse. In the last decade, the search for biomarkers that alone, or in combinations with Cal25, could improve prognostic testing for ovarian cancer yielded a number of candidates.
  • Candidate biomarker proteins which have been studied include: HE4 (6), osteopontin (7), prostasin (4, 5) and mesothelm/megakaryocyte potentiating factor (8). Recent reports also suggest that members of the kallikrein serine protease family, particularly kallikrein 10, may also serve as ovarian cancer biomarkers in blood (9, 10, 11). Results from exploratory studies are encouraging and suggest that these proteins either alone, or in combinations with other markers such as CA125, may be useful as prognostic indicators for ovarian cancer.
  • proteomic spectra generated by mass spectroscopy (SELDI-TOF) from sera of ovarian cancer patients and normal individuals and analyzed by an iterative searching algorithm, identified a proteomic profile of five, of as yet unidentified proteins, that completely discriminated the sera of the ovarian cancer patients (12).
  • the discriminatory pattern correctly identified 100% of the ovarian cancer samples including the 36% from early stage patients and showed a specificity (false positive rate) of 95% (12). If the positive predictive value of proteomic pattern technology is supported by population-based trials, these discriminating proteins provide excellent opportunities for developing highly sensitive diagnostic probes (13) which can, given the appropriate technology platforms, be ultimately exploited in routine tests for detecting early stage ovarian cancer.
  • the HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Research 63; 3695- 3700.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Laminated Bodies (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Selon l'invention, la lecture de réseaux fluorescents (103) dans des conditions cliniques peut être réalisée au moyen d'un lecteur (110) conçu pour utiliser un éclairage sur fond noir du réseau, et assurant le mappage d'une image du réseau sur un réseau de détecteurs à semi-conducteur (146) avec des dimensions d'image (D) du même ordre que les dimensions (D) du réseau fluorescent, de préférence avec une réduction d'image. On utilise un éclairage à haute intensité dont les non-uniformités sont compensées au moyen d'une normalisation utilisant des éléments d'étalonnage d'intensité (164) dans le réseau lui-même, ces éléments étant détectés pendant une imagerie du réseau. De préférence, on utilise des diodes électroluminescentes de haute intensité (122, 132, 402, 404), telles que celles utilisées dans les feux de circulation, pour l'excitation du réseau, cette excitation étant de préférence introduite dans le réseau par l'intermédiaire d'un homogénéisateur à réflexion interne solide (130). La profondeur intermédiaire de la collecte de champ et des éléments optiques d'imagerie permettent une collecte substantielle de lumière, l'ouverture numérique (O.N.) étant comprise entre 0,30 et 0,60, de préférence entre 0,4 et 0,55. Dans certains cas avantageux, la profondeur de champ relativement large résultante est compensée par absorption d'une lumière qui tend à se déplacer au-delà des points en cours d'imagerie, et qui, sinon, créerait un bruit de fluorescence, l'absorption étant produite, par exemple, au moyen d'une couche d'oxyde métallique opaque (304) intercalée entre un substrat (302), de préférence un substrat ultrafin sur lequel repose le réseau, et le verre ou un autre support rigide (306) nettement plus épais. On utilise des points de taille relativement importante, et notamment des points de diamètre de l'ordre d'au moins 80 à 100 microns ou, de préférence, de 150 à 300 microns. La résolution de ces points jusqu'à au moins 50 pixels sur le réseau de détecteurs à semi-conducteur implique la réalisation d'une mise en cellule appropriée et d'autres manipulations permettant d'obtenir des résultats très précis. Des nouvelles méthodes d'analyse et de diagnostic, tel que le diagnostic du cancer, utilisent ce lecteur pour détecter un ensemble de marqueurs associés à la maladie, et notamment au cancer de l'ovaire.
EP03788571A 2002-08-16 2003-08-18 Lecture de reseaux fluorescents Withdrawn EP1546723A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US40423702P 2002-08-16 2002-08-16
US404237P 2002-08-16
US43029902P 2002-12-02 2002-12-02
US430299P 2002-12-02
US47651203P 2003-06-06 2003-06-06
US476512P 2003-06-06
PCT/US2003/025702 WO2004017374A2 (fr) 2002-08-16 2003-08-18 Lecture de reseaux fluorescents

Publications (2)

Publication Number Publication Date
EP1546723A2 true EP1546723A2 (fr) 2005-06-29
EP1546723A4 EP1546723A4 (fr) 2007-03-07

Family

ID=31892097

Family Applications (3)

Application Number Title Priority Date Filing Date
EP10184800A Withdrawn EP2315027A1 (fr) 2002-08-16 2003-08-18 Substrats pour isoler, pour réagir et pour analyser des matériaux au microscope
EP03788571A Withdrawn EP1546723A4 (fr) 2002-08-16 2003-08-18 Lecture de reseaux fluorescents
EP03751862.8A Expired - Lifetime EP1546721B2 (fr) 2002-08-16 2003-08-18 Substrats d'isolation, de reaction et d'analyse microscopique de matieres

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10184800A Withdrawn EP2315027A1 (fr) 2002-08-16 2003-08-18 Substrats pour isoler, pour réagir et pour analyser des matériaux au microscope

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP03751862.8A Expired - Lifetime EP1546721B2 (fr) 2002-08-16 2003-08-18 Substrats d'isolation, de reaction et d'analyse microscopique de matieres

Country Status (4)

Country Link
EP (3) EP2315027A1 (fr)
JP (2) JP2006515065A (fr)
AU (2) AU2003276852A1 (fr)
WO (2) WO2004017374A2 (fr)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270960B2 (en) 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
US7576862B2 (en) 2003-08-26 2009-08-18 Blueshift Biotechnologies, Inc. Measuring time dependent fluorescence
BRPI0511003A (pt) 2004-05-13 2007-11-20 Applera Corp estruturas de lámina compósita para ensaio micro analìtico, dispositivo compósito, e, método para fabricar um dispositivo compósito
US7141378B2 (en) 2004-07-02 2006-11-28 Blueshift Biotechnologies, Inc. Exploring fluorophore microenvironments
FR2873815B1 (fr) * 2004-08-02 2006-11-24 Inodiag Sa Dispositif de lecture pour lames portant des micro depots supports de reaction biologique
WO2006137882A2 (fr) * 2004-09-22 2006-12-28 The Regents Of The University Of Michigan Modelisation de proteine reconfigurable au moyen de microelectrodes d'electromouillage
US20060166305A1 (en) * 2005-01-27 2006-07-27 Genetix Limited Animal cell confluence detection method and apparatus
US20060275852A1 (en) 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
JP4538746B2 (ja) * 2005-09-21 2010-09-08 横河電機株式会社 バイオチップおよび分析装置
EP1801593A1 (fr) * 2005-12-22 2007-06-27 Koninklijke Philips Electronics N.V. Une méthode d'imagérie d'échantillons biologiques au moyen des nanoparticules comme des agents de marquage
WO2007081768A2 (fr) * 2006-01-04 2007-07-19 Fujirebio America, Inc. Utilisation de he4 et d'autres marqueurs biochimiques dans l'évaluation de cancers de l'ovaire
US7286232B2 (en) * 2006-02-15 2007-10-23 Li-Cor, Inc. Fluorescence filtering system and method for molecular imaging
US7923054B2 (en) 2006-04-19 2011-04-12 Gore Enterprise Holdings, Inc. Functional porous substrates for attaching biomolecules
WO2008134811A1 (fr) * 2007-05-02 2008-11-13 Fluidyx Pty Ltd Dispositif portatif de lecture d'une puce sur membrane à marquage fluorescent
WO2009039170A2 (fr) * 2007-09-17 2009-03-26 Gentel Biosurfaces, Inc. Dosage de puce protéique intégré
JP5188228B2 (ja) * 2008-03-25 2013-04-24 東洋鋼鈑株式会社 蛍光標識された生体関連分子の検出方法
JP2011521237A (ja) * 2008-05-20 2011-07-21 ユニバーシティー ヘルス ネットワーク 螢光に基づく画像化およびモニタリング用装置ならびにその方法
KR20110046451A (ko) * 2008-08-29 2011-05-04 액텀 아이엔씨. 분석 스트립
WO2010121643A1 (fr) * 2009-04-20 2010-10-28 Agilent Technologies, Inc. Identification de marqueurs d'étalonnage dans des canaux de détection multiples
CA2811888A1 (fr) * 2009-09-21 2011-03-24 Akonni Biosystems Cartouche integree
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
US8809810B2 (en) 2010-05-20 2014-08-19 Honeywell International Inc. Microarray reader based on evanescent wave detection
JP2010281842A (ja) * 2010-09-24 2010-12-16 Yokogawa Electric Corp 光量計測装置および光量計測方法
JP2011017721A (ja) * 2010-09-24 2011-01-27 Yokogawa Electric Corp 光量計測装置および光量計測方法
CN102121898A (zh) * 2011-01-19 2011-07-13 云南烟草科学研究院 一种近红外样品检测装置
ITTO20110567A1 (it) * 2011-06-28 2012-12-29 St Microelectronics Srl Cartuccia per analisi biochimiche, sistema per analisi biochimiche e metodo per eseguire un processo biochimico
EP2780705B1 (fr) 2011-11-16 2018-09-19 Becton, Dickinson and Company Procédés et systèmes de détection d'un analyte dans un échantillon
EP2820174B1 (fr) 2012-02-27 2019-12-25 The University of North Carolina at Chapel Hill Procédés et utilisations d'étiquettes moléculaires
EP2820158B1 (fr) 2012-02-27 2018-01-10 Cellular Research, Inc. Compositions et trousses pour le comptage moléculaire
CN102927953B (zh) * 2012-11-08 2015-06-10 西南石油大学 一种剪切流动下聚合物水力学尺寸的测试方法及其测试装置
JP6296457B2 (ja) 2013-01-11 2018-03-20 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 低コストの臨床現場即時アッセイデバイス
GB2546833B (en) 2013-08-28 2018-04-18 Cellular Res Inc Microwell for single cell analysis comprising single cell and single bead oligonucleotide capture labels
US9582877B2 (en) * 2013-10-07 2017-02-28 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
BR112016009958B1 (pt) 2013-11-06 2021-08-03 Becton, Dickinson And Company Dispositivo microfluídico, método, sistema e kit
US10018640B2 (en) 2013-11-13 2018-07-10 Becton, Dickinson And Company Optical imaging system and methods for using the same
US9541750B2 (en) 2014-06-23 2017-01-10 Li-Cor, Inc. Telecentric, wide-field fluorescence scanning systems and methods
WO2015200803A1 (fr) * 2014-06-26 2015-12-30 The Trustees Of The University Of Pennsylvania Puces multipuits micro-fabriquées pour formation d'image automatisée à long terme de croissance et de comportement de c elegans
CN106714670A (zh) 2014-07-24 2017-05-24 大学健康网络 用于诊断目的的数据的收集和分析
WO2016134078A1 (fr) 2015-02-19 2016-08-25 Becton, Dickinson And Company Analyse à haut rendement de cellules uniques combinant des informations protéomiques et génomiques
CN107208158B (zh) 2015-02-27 2022-01-28 贝克顿迪金森公司 空间上可寻址的分子条形编码
JP7508191B2 (ja) 2015-03-30 2024-07-01 ベクトン・ディキンソン・アンド・カンパニー コンビナトリアルバーコーディングのための方法および組成物
WO2016172373A1 (fr) 2015-04-23 2016-10-27 Cellular Research, Inc. Procédés et compositions pour l'amplification de transcriptome entier
WO2016196229A1 (fr) 2015-06-01 2016-12-08 Cellular Research, Inc. Méthodes de quantification d'arn
EP3347465B1 (fr) 2015-09-11 2019-06-26 Cellular Research, Inc. Méthodes et composition pour la normalisation de bibliothèques d'acides nucléiques
AU2016340039B2 (en) * 2015-10-15 2021-10-14 Lumos Diagnostics IP Pty Ltd Device for reading an IVD assay
JP6953430B2 (ja) * 2016-04-22 2021-10-27 イラミーナ インコーポレーテッド ピクセル内における複数部位の発光性造影に使用するためのフォトニック構造をベースとしたデバイス及び組成物、並びにその使用方法
JP6818346B2 (ja) * 2016-04-28 2021-01-20 国立大学法人浜松医科大学 電子顕微鏡によるナノ粒子の直接的な同定・定量のための検出キットおよび方法
US10822643B2 (en) 2016-05-02 2020-11-03 Cellular Research, Inc. Accurate molecular barcoding
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
WO2017205691A1 (fr) 2016-05-26 2017-11-30 Cellular Research, Inc. Procédés de réglage de comptage d'étiquettes moléculaires
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
BR112018072475A2 (pt) * 2016-07-15 2019-02-19 Panasonic Intellectual Property Management Co., Ltd. método para determinar se ou não uma amostra de teste possui fungo fitopatogênico
WO2018047040A1 (fr) * 2016-09-08 2018-03-15 Presens Precision Sensing Gmbh Procédé de mesure optique étalonnée et système associé
CA3034924A1 (fr) 2016-09-26 2018-03-29 Cellular Research, Inc. Mesure d'expression de proteines a l'aide de reactifs avec des sequences d'oligonucleotides a code-barres
EP3539035B1 (fr) 2016-11-08 2024-04-17 Becton, Dickinson and Company Procédés destinés à la classification de profil d'expression
WO2018089377A1 (fr) 2016-11-08 2018-05-17 Cellular Research, Inc. Procédés de classification de marqueurs cellulaires
JP2020509391A (ja) 2017-01-10 2020-03-26 フォトスイッチ・バイオサイエンシズ・インコーポレイテッド 検出のためのシステムおよび方法
JP7104048B2 (ja) 2017-01-13 2022-07-20 セルラー リサーチ， インコーポレイテッド 流体チャネルの親水性コーティング
WO2018144240A1 (fr) 2017-02-01 2018-08-09 Cellular Research, Inc. Amplification sélective au moyen d'oligonucléotides de blocage
US10676779B2 (en) 2017-06-05 2020-06-09 Becton, Dickinson And Company Sample indexing for single cells
WO2018230575A1 (fr) * 2017-06-15 2018-12-20 オリンパス株式会社 Système de microscope
JP6994238B2 (ja) * 2017-11-07 2022-01-14 村角工業株式会社 刻印フロストスライドガラス及びフロストスライドガラスの刻印方法
CN111492068A (zh) 2017-12-19 2020-08-04 贝克顿迪金森公司 与寡核苷酸相关联的颗粒
GB2571743A (en) * 2018-03-07 2019-09-11 Pop Bio Ltd A method of capturing image data of a luminescent sample and apparatus for the same
US11365409B2 (en) 2018-05-03 2022-06-21 Becton, Dickinson And Company Molecular barcoding on opposite transcript ends
CN112272710A (zh) 2018-05-03 2021-01-26 贝克顿迪金森公司 高通量多组学样品分析
EP3861134B1 (fr) 2018-10-01 2024-09-04 Becton, Dickinson and Company Détermination de séquences de transcripts 5
US11932849B2 (en) 2018-11-08 2024-03-19 Becton, Dickinson And Company Whole transcriptome analysis of single cells using random priming
EP3894552A1 (fr) 2018-12-13 2021-10-20 Becton, Dickinson and Company Extension sélective dans une analyse de transcriptome complet de cellule unique
WO2020150356A1 (fr) 2019-01-16 2020-07-23 Becton, Dickinson And Company Normalisation de réaction en chaîne de la polymérase par titrage d'amorce
US11661631B2 (en) 2019-01-23 2023-05-30 Becton, Dickinson And Company Oligonucleotides associated with antibodies
CN113454234A (zh) 2019-02-14 2021-09-28 贝克顿迪金森公司 杂合体靶向和全转录物组扩增
JP7315356B2 (ja) 2019-03-28 2023-07-26 浜松ホトニクス株式会社 蛍光観察装置
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
WO2021016239A1 (fr) 2019-07-22 2021-01-28 Becton, Dickinson And Company Dosage de séquençage par immunoprécipitation de la chromatine monocellulaire
US11773436B2 (en) 2019-11-08 2023-10-03 Becton, Dickinson And Company Using random priming to obtain full-length V(D)J information for immune repertoire sequencing
WO2021146207A1 (fr) 2020-01-13 2021-07-22 Becton, Dickinson And Company Procédés et compositions pour la quantification de protéines et d'arn
CN115605614A (zh) 2020-05-14 2023-01-13 贝克顿迪金森公司（Us） 用于免疫组库谱分析的引物
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
CN116635533A (zh) 2020-11-20 2023-08-22 贝克顿迪金森公司 高表达的蛋白和低表达的蛋白的谱分析
DE102023101480A1 (de) 2023-01-20 2024-07-25 Testo bioAnalytics GmbH Verfahren und Detektionsbereich zur Aufzeichnung von Mikropartikeln und scheibenförmiger Probenträger

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075368A (ja) * 1993-06-17 1995-01-10 Fuji Photo Film Co Ltd 蛍光顕微鏡
DE19630322A1 (de) * 1995-07-28 1997-01-30 Lab Molecular Biophotonics Dunkelfeld-Auflicht-Fluoreszenzmikroskop
US6040940A (en) * 1998-02-04 2000-03-21 Olympus Optical Co., Ltd. Reflecting fluorescence microscope
WO2001067105A1 (fr) * 2000-03-06 2001-09-13 Dade Behring Marburg Gmbh Supports a revetement en polysaccharides, leur preparation et leur utilisation

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013467A (en) 1957-11-07 1961-12-19 Minsky Marvin Microscopy apparatus
JPS61152700A (ja) * 1984-12-26 1986-07-11 Susumu Kogyo Kk タンパク質固定用膜担体およびその製造法
JPH0814582B2 (ja) * 1986-02-20 1996-02-14 富士写真フイルム株式会社 免疫反応物定量用多層分析要素
JPH079087Y2 (ja) * 1987-04-13 1995-03-06 大日本印刷株式会社 検査シ−ト
JPS645486A (en) * 1987-06-29 1989-01-10 Hitachi Ltd Cell culture method and apparatus therefor
JPH01240188A (ja) * 1988-03-18 1989-09-25 Fuji Photo Film Co Ltd 機能性有機薄膜
US5720928A (en) * 1988-09-15 1998-02-24 New York University Image processing and analysis of individual nucleic acid molecules
EP0366241A3 (fr) * 1988-10-04 1990-05-23 Fisher Scientific Company Dispositif avec surface adsorbante et méthode de fabrication
US5491097A (en) * 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
WO1991004483A1 (fr) † 1989-09-18 1991-04-04 Biostar Medical Products, Inc. Appareil de detection d'un analyte immobilise
JP2869866B2 (ja) * 1989-10-06 1999-03-10 ティーディーケイ株式会社 電気化学発光検出用容器
US5096668A (en) * 1990-04-26 1992-03-17 Difco Laboratories Diagnostic test slide
US5784162A (en) * 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
WO1994007142A1 (fr) * 1992-09-14 1994-03-31 Sri International Rapporteurs a conversion vers le haut, destines a des dosages biologiques et autres effectues a l'aide de techniques d'excitation au laser
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
US6207369B1 (en) * 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
BR9607193B1 (pt) * 1995-03-10 2009-01-13 teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos.
US6017496A (en) * 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6165798A (en) * 1996-10-10 2000-12-26 University Of British Columbia Optical quantification of analytes in membranes
US6294327B1 (en) * 1997-09-08 2001-09-25 Affymetrix, Inc. Apparatus and method for detecting samples labeled with material having strong light scattering properties, using reflection mode light and diffuse scattering
JP2003521670A (ja) * 1997-10-31 2003-07-15 エルジェイエル・バイオシステムズ・インコーポレーテッド 蛍光偏光を測定する装置及びその方法
US6269846B1 (en) 1998-01-13 2001-08-07 Genetic Microsystems, Inc. Depositing fluid specimens on substrates, resulting ordered arrays, techniques for deposition of arrays
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
JP2002531470A (ja) * 1998-12-01 2002-09-24 シントリクス バイオチップ， インコーポレイテッド 支持体表面上で化学反応のアレイを行うための方法および組成物
US6951682B1 (en) * 1998-12-01 2005-10-04 Syntrix Biochip, Inc. Porous coatings bearing ligand arrays and use thereof
JP2001215181A (ja) * 2000-02-01 2001-08-10 Fuji Photo Film Co Ltd 顕微鏡観察用の高分子支持体
CA2399163A1 (fr) * 2000-02-18 2001-08-23 Pall Corporation Membranes
JP4222756B2 (ja) * 2000-05-04 2009-02-12 センター フォア ブラッド リサーチ インコーポレイテッド 固相生体分子分析調製同定システム用コロイド組成物
JP2001235473A (ja) * 2000-09-21 2001-08-31 Biostar Inc 固定化された分析物の検出装置
AU2002214404A1 (en) * 2000-10-26 2002-05-06 Glaucus Proteomics B.V. Products with biofunctional coating
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
EP1341934A4 (fr) * 2000-12-12 2005-04-06 Autogenomics Inc Puce a adn amelioree
US6505921B2 (en) * 2000-12-28 2003-01-14 Eastman Kodak Company Ink jet apparatus having amplified asymmetric heating drop deflection
JP2002214232A (ja) * 2001-01-12 2002-07-31 Toray Ind Inc 選択結合性物質固定化フィルム及びそれを用いた被検物質の測定方法
US6573051B2 (en) * 2001-03-09 2003-06-03 Molecular Staging, Inc. Open circle probes with intramolecular stem structures
EP2081396B1 (fr) † 2006-11-03 2012-12-12 Huawei Technologies Co., Ltd. Procédé de communication mobile et entité d'accès

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075368A (ja) * 1993-06-17 1995-01-10 Fuji Photo Film Co Ltd 蛍光顕微鏡
DE19630322A1 (de) * 1995-07-28 1997-01-30 Lab Molecular Biophotonics Dunkelfeld-Auflicht-Fluoreszenzmikroskop
US6040940A (en) * 1998-02-04 2000-03-21 Olympus Optical Co., Ltd. Reflecting fluorescence microscope
WO2001067105A1 (fr) * 2000-03-06 2001-09-13 Dade Behring Marburg Gmbh Supports a revetement en polysaccharides, leur preparation et leur utilisation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DONAL J. DENVIR, COLIN G. COATES: "Electron multiplying CCD technology: Application to ultrasensitive detection of biomolecules" PROCEEDINGS OF SPIE, BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS, vol. 4626, 20 January 2002 (2002-01-20), pages 502-512, XP002405341 *
HOOPER C. E., ANSORGE R. E.: "Quantitative photon imaging in the life sciences using intensified CCD cameras" BIOLUMINESCENCE AND CHEMILUMINESCENCE, PROCEEDINGS OF THE VITH INTERNATIONAL SYMPOSIUM ON BIOLUMINESCENCE AND CHMILUMINESCENCE, 1 January 1990 (1990-01-01), pages 337-344, XP001247827 *
See also references of WO2004017374A2 *

Also Published As

Publication number Publication date
WO2004017374A3 (fr) 2004-06-10
WO2004018623A2 (fr) 2004-03-04
EP1546721B2 (fr) 2017-05-17
JP2005535909A (ja) 2005-11-24
WO2004017374A2 (fr) 2004-02-26
EP1546723A4 (fr) 2007-03-07
JP4678516B2 (ja) 2011-04-27
EP1546721B1 (fr) 2012-08-01
AU2003276852A1 (en) 2004-03-03
AU2003276852A8 (en) 2004-03-03
AU2003269968A1 (en) 2004-03-11
JP2006515065A (ja) 2006-05-18
AU2003269968A8 (en) 2004-03-11
EP1546721A4 (fr) 2006-10-18
EP2315027A1 (fr) 2011-04-27
WO2004018623A3 (fr) 2004-04-15
EP1546721A2 (fr) 2005-06-29

Similar Documents

Publication Publication Date Title
WO2004017374A2 (fr) Lecture de reseaux fluorescents
US20060127946A1 (en) Reading of fluorescent arrays
US6905885B2 (en) Portable pathogen detection system
US11300513B2 (en) Device for reading an IVD assay
US9671345B2 (en) Mapping volumes of interest in selected planes in liquid samples
US20010052976A1 (en) Scanning optical detection system
US20050221279A1 (en) Method for creating chemical sensors using contact-based microdispensing technology
JP2006208294A (ja) プラズモン共鳴および蛍光の同時イメージング装置及びイメージング方法
US9523640B2 (en) Method of fluorescent measurement of samples, and devices therefrom
CN101287980A (zh) 用于光学分析物质的系统
WO2006038149A1 (fr) Procede et appareil pour la detection d'elements de marquage dans un echantillon
Barsky et al. Fluorescence data analysis on gel-based biochips
US20070098596A1 (en) Handheld microarray reader
US8428398B2 (en) Hand-held portable microarray reader for biodetection
WO2014039119A1 (fr) Systèmes et procédé pour imagerie à fluorescence
WO2003085387A1 (fr) Dispositif de detection d'une epifluorescence induite par laser
Peveler et al. Toward clinical applications of smartphone spectroscopy and imaging
US20200011862A1 (en) Apparatus and method for antibody detection
CN217304909U (zh) 可携式生物检测系统
JP2000131237A (ja) マイクロアレイチップの読取方法および読取装置
CN113755311B (zh) 一种基因芯片阅读仪
RU200805U1 (ru) Флуоресцентный анализатор биочипов
CN117070336A (zh) 一种数字聚合酶链式反应的荧光检测系统
KR20110137474A (ko) 바이오칩을 위한 진단장치
WO2013156820A1 (fr) Dispositif de mesure simultanée de multiples longueurs d'onde de fluorescence, procédés associés et système associé

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050218

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DECISION BIOMARKERS INCORPORATED

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): CH DE FR GB LI

A4 Supplementary search report drawn up and despatched

Effective date: 20070201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301